Does OBINUTUZUMAB Cause Progressive multifocal leukoencephalopathy? 81 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Progressive multifocal leukoencephalopathy have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.6% of all adverse event reports for OBINUTUZUMAB.
81
Reports of Progressive multifocal leukoencephalopathy with OBINUTUZUMAB
0.6%
of all OBINUTUZUMAB reports
28
Deaths
35
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From OBINUTUZUMAB?
Of the 81 reports, 28 (34.6%) resulted in death, 35 (43.2%) required hospitalization, and 14 (17.3%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which OBINUTUZUMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE